Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.22.4
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 5,935,718 7,705,090
General and administrative 6,452,579 7,703,065
Total operating expenses 12,388,297 15,408,155
Operating loss (12,388,297) (15,408,155)
Other income (expense):    
Interest income 223,291 5,578
Interest expense (1,479) (40,108)
Amortization of debt discount and offering costs (8,723) (33,091)
Total other income (expense) 213,089 (67,621)
Net loss $ (12,175,208) $ (15,475,776)
Basic and diluted net loss per share (in Dollars per share) $ (4.2) $ (6.97)
Weighted average common shares outstanding - basic and diluted (in Shares) 2,900,202 2,220,981